(lp0
S"Vanda Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial ... PR Newswire  - Feb 15, 2017 15, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , today announced financial and operational results for the fourth quarter and full year ended December 31, 2016.Vanda Pharmaceuticals'  CEO Mihael Polymeropoulos on Q4 2016 Results ... - Seeking AlphaVanda Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 17 - Equities.com"
p1
aS'Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial ... PR Newswire  - Jan 19, 2017 To participate in the conference call, please dial 1-888-771-4371  or 1-847-585-4405  and use passcode 44159815.'
p2
aS"What are Analyst's Indicators for Vanda Pharmaceuticals Inc. , Align ... The USA Commerce - 19 hours ago Presently Vanda Pharmaceuticals Inc.  stock have an ABR of 1.00. This is built on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell."
p3
aS'Vanda Pharmaceuticals Announces Participation at March 2017 Investor Conferences PR Newswire  - Mar 6, 2017 WASHINGTON, March 6, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced that it will participate at the following upcoming investor conferences in March 2017.Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Announces Participation at ... - The Wall Street TranscriptVanda Pharmaceuticals Inc.  Median Target At $22 - Markets Daily'
p4
aS'Vanda Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial ... PR Newswire  - Feb 10, 2016 10, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , today announced financial and operational results for the fourth quarter and full year ended December 31, 2015.'
p5
aS"Why to Keeping Eye on Gogo Inc. , Vanda Pharmaceuticals Inc. ? StockNewsJournal - 19 hours ago Vanda Pharmaceuticals Inc. , at its latest closing price of $13.90, it has a price-to-book ratio of 4.74, compared to an industry average at 10.15.Vanda Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 21 - Equities.comWhat's Happening To These Stocks?  Vanda Pharmaceuticals Inc. , Gray ... - Post Analyst"
p6
aS"Vanda Pharmaceuticals Reports Third Quarter 2016 Financial Results PR Newswire  - Nov 2, 2016 WASHINGTON, Nov. 2, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , today announced financial and operational results for the third quarter ended September 30, 2016.Vanda Pharmaceuticals'  CEO Mihael Polymeropoulos on Q3 2016 Results ... - Seeking Alpha"
p7
aS"Kenneth Bate Joins the Board of Directors of Vanda Pharmaceuticals PR Newswire  - Dec 18, 2015 WASHINGTON, Dec. 18, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc.  , announced today that Kenneth Bate, an independent biotechnology industry consultant, has joined Vanda's Board of Directors."
p8
aS'Vanda Pharmaceuticals appoints Gian Piero Reverberi as Acting Chief Commercial ... PR Newswire  - Dec 17, 2015 WASHINGTON, Dec. 17, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced that it has appointed Gian Piero Reverberi to the role of Senior Vice President, Acting Chief Commercial Officer and European General&nbsp;...'
p9
aS"Vanda Patents Found Valid and Infringed in Fanapt ANDA Litigation PR Newswire  - Aug 25, 2016 WASHINGTON, Aug. 25, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced that Judge Gregory M. Sleet of the United States District Court for the District of Delaware ruled that Roxane Laboratories Inc. &nbsp;...Brean Capital Take on Vanda Pharmaceuticals Inc.'s  Patent Win; Raises ... - Smarter AnalystVanda Pharmaceuticals  Stock Soars on Drug Patent Ruling - TheStreet.com"
p10
a.